| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
96,356,005 | 77,484,652 | 65,089,892 | 56,904,659 | 1,228,439 |
| Cost of Revenue
|
-77,598,319 | -65,110,788 | -56,966,552 | -51,748,425 | -906,067 |
|
Gross Profit
|
18,757,686 | 12,373,864 | 8,123,340 | 5,156,234 | 322,372 |
| Selling, General and Administrative Expenses
|
-1,861,089 | -1,434,295 | -1,194,146 | -1,018,185 | -156,417 |
|
Research and Development Expenses
|
-274,983 | -240,188 | -200,744 | -185,001 | -36,818 |
|
Operating Income/Expenses
|
-2,136,072 | -1,674,483 | -1,394,890 | -1,203,186 | -193,235 |
|
Total Operating Profit/Loss
|
16,621,614 | 10,699,381 | 6,728,450 | 3,953,048 | 129,137 |
| Total Net Finance Income/Expense
|
499,028 | 507,961 | 497,522 | 425,413 | -4,106 |
| Net Investment Income
|
-- | -- | -- | 0 | 0 |
| Irregular Income/Expenses
|
-405,646 | -643,373 | -103,318 | 60,267 | -125 |
|
Other Income/Expense, Non-Operating
|
2,538,796 | 1,294,718 | 148,153 | 98,569 | 114,046 |
|
Non-Operating Income/Expenses, Total
|
2,632,178 | 1,159,306 | 542,357 | 584,249 | 109,815 |
|
Pretax Income
|
19,253,792 | 11,858,687 | 7,270,807 | 4,537,297 | 238,952 |
|
Provision for Income Tax
|
-4,033,115 | -2,642,850 | -1,647,314 | -993,956 | -26,775 |
|
Net Income from Continuing Operations
|
15,220,677 | 9,215,837 | 5,623,493 | 3,543,341 | 212,177 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
15,220,677 | 9,215,837 | 5,623,493 | 3,543,341 | 212,177 |
|
Non-Controlling/Minority Interests
|
-3,527,032 | -2,070,867 | -1,287,985 | -654,521 | -2,143 |
|
Net Income after Non-Controlling/Minority Interests
|
11,693,645 | 7,144,970 | 4,335,508 | 2,888,820 | 210,034 |
|
Net Income Available to Common Stockholders
|
11,693,645 | 7,144,970 | 4,335,508 | 2,888,820 | 210,034 |
|
Diluted Net Income Available to Common Stockholders
|
11,693,645 | 7,144,970 | 4,335,508 | 2,888,820 | 210,034 |
| Basic EPS
|
49.73 | 30.51 | 18.73 | 12.81 | 4.29 |
| Diluted EPS
|
49.62 | 30.41 | 17.90 | 12.74 | 4.28 |
|
Basic Weighted Average Shares Outstanding
|
235,354.92 | 234,184.53 | 231,474 | 225,512.88 | 227,455.18 |
|
Diluted Weighted Average Shares Outstanding
|
235,354.92 | 234,954.62 | 242,207.15 | 226,751.96 | 228,205.79 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
18,754,764 | 11,350,726 | 6,773,285 | 4,111,884 | 243,058 |
|
EBITDA
|
18,976,060 | 11,565,877 | 6,990,983 | 4,347,124 | 287,124 |
|
Normalized EBITDA
|
17,896,134 | 10,863,818 | 7,135,047 | 4,231,514 | 251,200 |
|
Normalized Income
|
14,366,964.18 | 8,670,240.27 | 5,734,917.14 | 3,453,056.87 | 180,278.36 |
|
Total Unusual Items
|
-1,079,926 | -702,059 | 144,064 | -115,610 | -35,924 |
12/31/2022 - 8/25/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade